Paragon specializes in helping clients build a Unified Extended Enterprise� for
better business results and competitive advantage.
To that end, we incorporate
the most appropriate technology, practices, methodologies and people to create
an integrated, performance-driven and client-focused organization.
Life Sciences Solutions: Preclinical Drug Development
Getting Answers to Questions that Help Strengthen Your Pipeline
A Redefined Competitive Landscape...
New technologies enable integration and collaboration in ways that are challenging conventional methods of
monitoring the drug pipeline. Currently, most business information about preclinical activities resides on disparate,
multiple platforms. Users have to access separate systems to extract, compile, and assemble reports from multiple
laboratory operations.
To compound this problem, the network of preclinical information consumers - from the vice president of
research to laboratory project managers - requires information on unique, although interdependent, key
performance indicators (KPIs). With such an environment, how do you deliver throughput increases or
avoid unnecessary costs?
Imagine if you could do more...
What would it mean if your laboratory operations
could investigate more candidates with the same number of resources, or you could
uncover candidate failure before clinical development? All without risking the
integrity of your business data or replacing the systems that house these data?
